12:00 AM
Jul 23, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Imvamune regulatory update

Bavarian said the U.S. government authorized the use of its Imvamune smallpox vaccine during an emergency to include patients with HIV infection or atopic dermatitis. Previously, only...

Read the full 112 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >